Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Operating expenses:
Research and development	$ 5,143	$ 5,269
General and administrative	4,589	5,605
Total operating expenses	9,732	10,874
Loss from operations	(9,732)	(10,874)
Other income (expense), net:
Interest and investment income	687	119
Other income (expense), net	687	119
Net loss	$ (9,045)	$ (10,755)
Net loss per share attributable to common stockholders, basic (in Dollars per share)	$ (0.8)	$ (0.96)
Weighted-average shares outstanding, basic (in Shares)	11,303,869	11,250,127
Other comprehensive income (loss):
Net unrealized gain (loss) on marketable debt securities	$ 219	$ (731)
Other comprehensive income (loss)	219	(731)
Comprehensive Loss	$ (8,826)	$ (11,486)